Patents by Inventor Haruki Mori

Haruki Mori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4376768
    Abstract: N-(6-chloro-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-ca rboxamide 1,1-dioxide that is a novel benzothiazine derivative. The compound is characterized by a low degree of toxicity and a low incidence of gastric disorders and useful as an anti-inflammatory agent.
    Type: Grant
    Filed: June 16, 1981
    Date of Patent: March 15, 1983
    Assignee: Mitsui Toatsu Chemicals, Inc.
    Inventors: Shoichiro Ozaki, Hideya Kobayashi, Haruki Mori, Takafumi Kitano, Hiroshi Kawazura, Yutaka Okazaki
  • Patent number: 4376119
    Abstract: N-(6-fluoro-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-ca rboxamide 1,1-dioxide that is a novel benzothiazine derivative. The compound is characterized by a low degree of toxicity and a low incidence of gastric disorders and useful as an anti-inflammatory agent.
    Type: Grant
    Filed: June 16, 1981
    Date of Patent: March 8, 1983
    Assignee: Mitsui Toatsu Chemicals, Inc.
    Inventors: Shoichiro Ozaki, Hideya Kobayashi, Haruki Mori, Hiroshi Kawazura, Yutaka Okazaki, Takafumi Kitano, Mikio Kumakura, Takuo Nakano
  • Patent number: 4267326
    Abstract: New uracil derivatives of the general formula: ##STR1## wherein R.sup.1 stands for a hydrogen atom or a grouping of the formula: ##STR2## R.sup.2 for a hydrogen atom, an alkyl group or a phenyl group and R.sup.3 for an alkyl group or a phenyl group, with the proviso that when both R.sup.1 and R.sup.2 stand for a hydrogen atom, R.sup.3 stands for a phenyl group or a straight chain alkyl group with 3.about.11 carbon atoms, that when R.sup.1 stands for a hydrogen atom and R.sup.2 for methyl group, R.sup.3 stands for an alkyl group with at least 2 carbon atoms or a phenyl group, and that when R.sup.1 stands for a hydrogen atom and R.sup.3 for methyl group, R.sup.2 stands for an alkyl group with at least 2 carbon atoms or a phenyl group. These uracil derivatives are prepared by reacting 5-fluorouracil with an .alpha.-haloalkyl carboxylate or with an aldehyde diacylate or by hydrolyzing a 1,3-bis(acyloxymethyl)-5-fluorouracil with an acid or alkali.
    Type: Grant
    Filed: February 26, 1979
    Date of Patent: May 12, 1981
    Assignee: Mitsui Toatsu Chemicals, Incorporated
    Inventors: Shoichiro Ozaki, Yoshimasa Ike, Katsutoshi Ishikawa, Haruki Mori
  • Patent number: 4078479
    Abstract: Disclosed is a cooking utensil capable of cooking food without burning, which is characterized by the fact that the inner side of the bottom plate thereof contains a circular concave at the center thereof, radial rows of concaves disposed outside the circumference of said central circular concave and as many radial rows interposed one each between the adjacent ones of said first radial rows and each consisting of a circular concave and two convexes disposed opposite each other across said circular concave and the bottom side of said bottom plate contains convexes and concaves respectively at positions exactly corresponding to those of concaves and convexes on the inner side.
    Type: Grant
    Filed: May 25, 1976
    Date of Patent: March 14, 1978
    Inventor: Haruki Mori
  • Patent number: 4071519
    Abstract: 1-Carbamoyl-5-fluorouracil derivatives represented by the formula ##STR1## wherein R represents alkyl containing 3-8 carbon atoms are effective oral anti-tumor agents with low toxicity.
    Type: Grant
    Filed: November 5, 1975
    Date of Patent: January 31, 1978
    Assignee: Mitsui Toatsu Chemicals, Incorporated
    Inventors: Shoichiro Ozaki, Haruki Mori
  • Patent number: 4032524
    Abstract: 1-Carbamoyl-5-fluorouracil derivatives represented by the formula ##STR1## wherein R.sub.1 represents methyl, ethyl, phenyl or cyclohexyl and R.sub.2 represents hydrogen or is the same as R.sub.1 are effective anti-metabolites useful in treating lymphatic leukemia L1210, sarcoma 180A and Ehrlich ascites carcinoma in mice.
    Type: Grant
    Filed: September 24, 1976
    Date of Patent: June 28, 1977
    Assignee: Mitsui Toatsu Chemicals, Incorporated
    Inventors: Shoichiro Ozaki, Haruki Mori